Cargando…
Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
Autores principales: | Swatler, Julian, Lo Tartaro, Domenico, Borella, Rebecca, Brewinska-Olchowik, Marta, Paolini, Annamaria, Neroni, Anita, TurosKorgul, Laura, Wiech, Milena, Kozlowska, Ewa, Cysewski, Dominik, Grabowska-Pyrzewicz, Wioleta, Wojda, Urszula, Basak, Grzegorz, Argüello, Rafael J., Cossarizza, Andrea, De Biasi, Sara, Piwocka, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973468/ https://www.ncbi.nlm.nih.gov/pubmed/36384249 http://dx.doi.org/10.3324/haematol.2022.281713 |
Ejemplares similares
-
4-1BBL–containing leukemic extracellular vesicles promote immunosuppressive effector regulatory T cells
por: Swatler, Julian, et al.
Publicado: (2022) -
Chronic myeloid leukemia‐derived extracellular vesicles increase Foxp3 level and suppressive activity of thymic regulatory T cells
por: Swatler, Julian, et al.
Publicado: (2019) -
Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias
por: Swatler, Julian, et al.
Publicado: (2021) -
Targeting integrated stress response with ISRIB combined with imatinib treatment attenuates RAS/RAF/MAPK and STAT5 signaling and eradicates chronic myeloid leukemia cells
por: Dudka, Wioleta, et al.
Publicado: (2022) -
Remodeling of T Cell Dynamics During Long COVID Is Dependent on Severity of SARS-CoV-2 Infection
por: Wiech, Milena, et al.
Publicado: (2022)